17 related articles for article (PubMed ID: 38627234)
1. Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma.
Yang X; Li S; Xu C; Liu S; Zhang X; Lian B; Li M
Cancer Biol Ther; 2024 Dec; 25(1):2365449. PubMed ID: 38865161
[TBL] [Abstract][Full Text] [Related]
2. Endowing Pt(IV) with Perfluorocarbon Chains and Human Serum Albumin Encapsulation for Highly Effective Antitumor Chemoimmunotherapy.
Xie P; Jin Q; Zhang L; Zhang H; Montesdeoca N; Karges J; Xiao H; Mao X; Song H; Shang K
ACS Nano; 2024 May; 18(21):13683-13695. PubMed ID: 38749906
[TBL] [Abstract][Full Text] [Related]
3. Construction Protocol of Drug-Protein Cage Complexes for Drug Delivery System.
Nakahara Y; Endo Y; Inoue I
Methods Mol Biol; 2023; 2671():335-347. PubMed ID: 37308654
[TBL] [Abstract][Full Text] [Related]
4. Cancer cell membrane fused liposomal platinum(IV) prodrugs overcome cisplatin resistance in esophageal squamous cell carcinoma chemotherapy.
Zhang S; Jiang W; Wang S; Song K; Ge M; Zhang L; Yan X; Jiang B
J Mater Chem B; 2023 Dec; 11(47):11384-11393. PubMed ID: 38014915
[TBL] [Abstract][Full Text] [Related]
5. Corilagin Inhibits Esophageal Squamous Cell Carcinoma by Inducing DNA Damage and Down-Regulation of RNF8.
Qiu F; Liu L; Lin Y; Yang Z; Qiu F
Anticancer Agents Med Chem; 2019; 19(8):1021-1028. PubMed ID: 30848215
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
7. Tackling Esophageal Squamous Cell Carcinoma with ITFn-Pt(IV): A Novel Fusion of PD-L1 Blockade, Chemotherapy, and T-cell Activation.
Xin Q; Wang D; Wang S; Zhang L; Liang Q; Yan X; Fan K; Jiang B
Adv Healthc Mater; 2024 Apr; 13(11):e2303623. PubMed ID: 38142309
[TBL] [Abstract][Full Text] [Related]
8. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L
Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417
[TBL] [Abstract][Full Text] [Related]
9. Structure-Guided Design of Ferritin-Platinum Prodrugs for Targeted Therapy of Esophageal Squamous Cell Carcinoma.
Jiang B; Chen X; Wang S; Wang S; Ma S; Lu Y; Ma L; Liang Q; Xiao H; Zhang L; Yan X; Fan K
ACS Nano; 2024 Apr; 18(17):11217-11233. PubMed ID: 38627234
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
